Scandinavian ChemoTech AB (publ) (FRA:8V6)
Germany flag Germany · Delayed Price · Currency is EUR
0.3220
+0.0160 (5.23%)
Last updated: Feb 23, 2026, 8:21 AM CET

Scandinavian ChemoTech AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.670.950.925.858.68
Cash & Short-Term Investments
3.670.950.925.858.68
Cash Growth
286.51%2.82%-84.23%-32.60%484.65%
Accounts Receivable
2.681.250.120.860.65
Other Receivables
-0.641.040.810.88
Receivables
2.681.891.161.671.53
Inventory
2.793.314.033.12.25
Prepaid Expenses
-1.621.091.20.97
Other Current Assets
---0--
Total Current Assets
9.147.777.211.8213.44
Property, Plant & Equipment
0.1200.010.040.07
Other Intangible Assets
3.792.092.22.091.76
Long-Term Deferred Charges
-3.355.257.3410.39
Other Long-Term Assets
0.160.170.210.420.15
Total Assets
13.213.3814.8721.725.81
Accounts Payable
-1.422.391.821.01
Accrued Expenses
-0.81.070.820.52
Current Portion of Long-Term Debt
----0.05
Other Current Liabilities
10.015.180.385.070.31
Total Current Liabilities
10.017.43.847.711.89
Total Liabilities
10.017.43.847.711.89
Common Stock
3.1911.678.976.014.82
Additional Paid-In Capital
-116.89111.0595.6384.27
Retained Earnings
--13.72-21.09-22.75-17.74
Comprehensive Income & Other
--108.87-87.9-64.9-47.43
Shareholders' Equity
3.195.9811.0313.9923.92
Total Liabilities & Equity
13.213.3814.8721.725.81
Total Debt
----0.05
Net Cash (Debt)
3.670.950.925.858.63
Net Cash Growth
286.51%2.82%-84.23%-32.18%-
Net Cash Per Share
0.150.050.070.591.00
Filing Date Shares Outstanding
25.4523.3417.9412.019.63
Total Common Shares Outstanding
25.4523.3417.9412.019.63
Working Capital
-0.880.373.364.1111.54
Book Value Per Share
0.130.260.611.162.48
Tangible Book Value
-0.63.898.8311.922.16
Tangible Book Value Per Share
-0.020.170.490.992.30
Machinery
-0.320.320.320.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.